(Q52546912)

3 May 2018

title

Survival signaling mediated by c-Jun NH(2)-terminal kinase in transformed B lymphoblasts. (English)

1 reference

3 May 2018

4

Richard A Flavell

1 reference

3 May 2018

Roger John Davis

5

object named as

Roger J Davis

1 reference

3 May 2018

author name string

Patricia Hess

1

1 reference

3 May 2018

German Pihan

2

1 reference

3 May 2018

Charles L Sawyers

3

1 reference

3 May 2018

language of work or name

English

0 references

publication date

5 August 2002

1 reference

3 May 2018

published in

Nature Genetics

1 reference

3 May 2018

volume

32

1 reference

3 May 2018

page(s)

201-205

1 reference

3 May 2018

issue

1

1 reference

3 May 2018

https://scigraph.springernature.com/pub.10.1038/ng946

exact match

0 references

cites work

Signal transduction by the JNK group of MAP kinases

1 reference

7 January 2021

Chronic myeloid leukemia

1 reference

7 January 2021

The Bcr-Abl leukemia oncogene activates Jun kinase and requires Jun for transformation

1 reference

7 January 2021

A cytoplasmic inhibitor of the JNK signal transduction pathway

1 reference

7 January 2021

In vitro transformation of immature hematopoietic cells by the P210 BCR/ABL oncogene product of the Philadelphia chromosome

1 reference

7 January 2021

The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity

1 reference

7 January 2021

Blast crisis in a murine model of chronic myelogenous leukemia

1 reference

7 January 2021

Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies

1 reference

7 January 2021

Blockade of the Bcr-Abl kinase activity induces apoptosis of chronic myelogenous leukemia cells by suppressing signal transducer and activator of transcription 5-dependent expression of Bcl-xL

1 reference

7 January 2021

Posttranslational modification of Bcl-2 facilitates its proteasome-dependent degradation: molecular characterization of the involved signaling pathway.

1 reference

7 January 2021

The Bcr-Abl tyrosine kinase activates mitogenic signaling pathways and stimulates G1-to-S phase transition in hematopoietic cells

1 reference

7 January 2021

The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf.

1 reference

7 January 2021

Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway.

1 reference

7 January 2021

Tumorigenic activity of the BCR-ABL oncogenes is mediated by BCL2.

1 reference

7 January 2021

Akt/protein kinase B up-regulates Bcl-2 expression through cAMP-response element-binding protein.

1 reference

7 January 2021

BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias

1 reference

7 January 2021

Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization

1 reference

7 January 2021

Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis

1 reference

7 January 2021

Alternative signals to RAS for hematopoietic transformation by the BCR-ABL oncogene

1 reference

7 January 2021

Enforced BCL2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease

1 reference

7 January 2021

Defective T Cell Differentiation in the Absence of Jnk1

1 reference

7 January 2021

Production of high-titer helper-free retroviruses by transient transfection

1 reference

7 January 2021

Murine B cell lymphopoiesis in long term culture

1 reference

7 January 2021

Identifiers

DOI

10.1038/NG946

1 reference

3 May 2018

PubMed ID

12161751

1 reference

3 May 2018